Company Profile

Gabaeron Inc
Profile last edited on: 10/8/2019      CAGE: 809D2      UEI: RVDNEZQNYZN3

Business Identifier: Therapeutics to preserve (restore) brain function in Alzheimer’s disease
Year Founded
2018
First Award
2018
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

325 Berry Street Unit 327
San Francisco, CA 94158
   (415) 734-2061
   N/A
   www.gabaeron.com
Location: Single
Congr. District: 11
County: San Francisco

Public Profile

Spun out of the Gladstone Institutes - an internationally-known 450 person facility affiliated with the University of California San Francisco and structured around work in the spaces of heart disease, cholesterol metabolism and Alzheimer’s disease - GABAeron as a start-up biotech company intended to focus specifically on Alzheimer’s disease. GABAeron is addressing engineered stem cell lines, genetic data and small-molecule drugs ias part of a concerted effort to develop therapeutics to preserve and maybe restore brain function in Alzheimer’s disease. .

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Robert W Mahley -- Senior investigator

  Wen-Chin (Danny) Huang Scientist -- Scientist

Company News

There are no news available.